Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

ORPH.L (ORPH) Regulatory News

Date Source Headline
14th Jul 2021 8:04 am RNS AIM Schedule 1 update by Poolbeg Pharma plc
14th Jul 2021 7:01 am RNS New Contract win for Open Orphan’s Breda office
14th Jul 2021 7:00 am RNS COVID-19 Human Challenge Programme update
9th Jul 2021 7:00 am RNS HRV and Flu contract
7th Jul 2021 4:41 pm RNS Second Price Monitoring Extn
7th Jul 2021 4:36 pm RNS Price Monitoring Extension
30th Jun 2021 7:00 am RNS 2020 Annual Report and 2021 AGM Notice
17th Jun 2021 7:00 am RNS Final Results to 31 December 2020
17th Jun 2021 7:00 am RNS Demerger Update
14th Jun 2021 7:00 am RNS Re. Distribution in Specie and Notice of Results
11th Jun 2021 7:00 am RNS Exercise of Warrants
19th May 2021 7:00 am RNS Court Approval
10th May 2021 7:15 am RNS Exercise of Share Options
10th May 2021 7:00 am RNS £3m COVID challenge virus manufacturing contract
29th Apr 2021 11:39 am RNS Result of General Meeting
13th Apr 2021 7:00 am RNS Potential demerger of certain non-core assets
9th Apr 2021 7:00 am RNS Launch of Disease in Motion platform
31st Mar 2021 7:00 am RNS Holding(s) in Company
26th Mar 2021 7:00 am RNS £7.5m Human Challenge Study Contract
25th Mar 2021 7:00 am RNS COVID-19 Human Challenge Programme update
11th Mar 2021 7:00 am RNS Journal for Clinical Studies article publication
9th Mar 2021 7:00 am RNS New contract win with Oxford BioTherapeutics
26th Feb 2021 4:58 pm RNS Holding(s) in Company
17th Feb 2021 9:00 am RNS Ethics approval - COVID-19 Human Challenge Study
9th Feb 2021 3:57 pm RNS Holding(s) in Company
3rd Feb 2021 7:05 am RNS Exercise of Investor Warrants & TVR
3rd Feb 2021 7:00 am RNS New challenge study quarantine clinic
1st Feb 2021 7:00 am RNS Contract extension with Carna Biosciences
21st Jan 2021 7:00 am RNS Article published in Drug Discovery Today
20th Jan 2021 7:00 am RNS Expansion of volunteer recruitment centres
11th Jan 2021 7:00 am RNS First volunteer dosed in COVID-19 clinical trial
6th Jan 2021 4:29 pm RNS Holding(s) in Company
6th Jan 2021 7:00 am RNS Contract renewal with top-3 pharmaceutical client
31st Dec 2020 7:00 am RNS Rule 19.6(c) Confirmation
23rd Dec 2020 7:00 am RNS Successful completion of toxicology study
22nd Dec 2020 7:00 am RNS Contract renewal with top-3 pharmaceutical client
14th Dec 2020 7:30 am RNS Exercise of Share Options
14th Dec 2020 7:00 am RNS MHRA approval for nasal COVID-19 vaccine trial
7th Dec 2020 7:00 am RNS Venn Life Sciences contract wins
24th Nov 2020 7:00 am RNS Directors Change
FTSE 100 Latest
Value8,809.74
Change53.53